The role of osteopontin in recovery from hind limb ischemia.

Duvall CL, Weiss D, Robinson ST, Alameddine FM, Guldberg RE, Taylor WR
Arterioscler Thromb Vasc Biol. 2008 28 (2): 290-5

PMID: 18006856 · DOI:10.1161/ATVBAHA.107.158485

OBJECTIVE - Osteopontin (OPN) is a highly phosphorylated extracellular matrix glycoprotein that is involved in a diversity of biological processes. In the vascular wall, OPN is produced by monocytes/macrophages, endothelial cells, and smooth muscle cells, and it is thought to mediate adhesion, migration, and survival of these cell types. In this study, we hypothesized that OPN plays a critical role in recovery from limb ischemia.

METHODS AND RESULTS - We induced hind limb ischemia in wild-type and OPN-/- mice. OPN-/- mice exhibited significantly delayed recovery of ischemic foot perfusion as determined by LDPI, impaired collateral vessel formation as measured using micro-CT, and diminished functional capacity of the ischemic limb. In the aortic ring assay, normal endothelial cell sprouting was found in OPN-/- mice. However, OPN-/- peritoneal monocytes/macrophages were found to possess significantly reduced migration in response to chemoattraction.

CONCLUSIONS - This study provides evidence that a definitive biological role exists for OPN during ischemic limb revascularization, and we have suggested that this may be driven by impaired monocyte/macrophage migration in OPN-/- mice. These findings provide the first in vivo evidence that OPN may be a key regulator in postnatal vascular growth.

MeSH Terms (11)

Animals Endothelial Cells Hindlimb Ischemia Lower Extremity Macrophages Male Mice Neovascularization, Physiologic Osteopontin Recovery of Function

Connections (1)

This publication is referenced by other Labnodes entities:

Links